For investors

Ensemble is the neutral AI orchestration platform. As frontier models specialise and the incumbents stay locked to their own model, a vendor-neutral layer that routes, assembles and fuses across all of them is the missing piece. We're raising a pre-seed round to reach first paying customers.

Why now

$14B→$60B

AI orchestration market, 2026→2034 (~20% CAGR). Figures from market-research reports; verify independently.

Specialisation

No single model wins every task — code, images, reasoning and video each have different leaders, and it keeps shifting.

Neutrality

OpenAI will never route you to a rival. A neutral orchestrator always can — a structural edge the incumbents can't copy.

The product & the moat

1

Auto-route

Ensemble knows the best model for each part of your task and chains specialists — architecture → code → testing for engineering, script → Veo for video, plus writing, images, reasoning and live facts. You stop guessing which tool wins this month.

2

Finished deliverables

It doesn't hand you four answers to stitch together. It assembles text and generated images into one complete PDF, slide deck or Word document, ready to use.

3

Fusion

For high-stakes work, several models tackle the same task and the strongest answer is synthesized — producing output that beats any single model on its own.

4

Train once

One place to train and set up all your AI — your prompts, context and preferences live in a single spot and apply across every model. With separate tools you’d set up and re-train each one individually.

The routing trick is copyable; the defensible value is neutrality, the cross-model assembly layer, and proprietary routing/evaluation data that compounds as models change.

The round

£1m

pre-seed raise · ~20 months runway · SEIS + EIS (UK)

MVP built

Working product: auto-routing, multi-format deliverables, fusion, web + desktop apps. Pre-launch.

B2B-first

Vertical wedge as the revenue engine; B2C launch as an awareness spike.

Figures are illustrative and pre-launch; the product has no revenue yet. Valuation and terms are subject to negotiation. Nothing here is an offer of securities.

Request the deck